Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2008 014 150.0 |
96 | EP file number | EAKZ | 08 79 5303.0 |
86 | WO file number | WAKZ | PCT/US2008/009703 |
97 | EP publication number | EPN | 2187741 |
87 | WO publication number | WPN | 2009023232 |
54 | Designation/title | TI | NEUE FORMEN VON CDDO-METHYLESTER |
51 | IPC main class | ICM (ICMV) | A61K 45/06 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 35/00 (2006.01) |
22 | DE application date | DAT | Aug 14, 2008 |
96 | EP application date | EAT | Aug 14, 2008 |
86 | WO application date | WAT | Aug 14, 2008 |
43 | Date of first publication | OT | Feb 19, 2009 |
| Date of publication of grant | PET | Mar 14, 2012 |
71/73 | Applicant/owner | INH | Reata Pharmaceuticals Holdings, LLC, Plano, TX, US |
72 | Inventor | IN | PARENT, Stephan, D., W. Lafayette, IN 47906, US; JONAITIS, David, T., Lafayette, IN 47901, US; KRAL, Robert, M., Grapevine, Texas 76051, US; WALLING, John, Irving, TX 75063, US |
74 | Representative | VTR | Plougmann Vingtoft a/s, Hellerup, DK |
| Address for service | | Plougmann & Vingtoft A/S, 2100 KOPENHAGEN O, DK |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 955939 P Aug 15, 2007
|
| Due date | FT FG | Aug 31, 2025 Annual fee for the 18th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR |
81 | Designated WO countries | WDS | AL, RS, BA, MK |
| Published EP/WO documents | EPWOPN | Original document:
EP000002187741 Searchable text:
EP000002187741 Original document:
EP000002187741B1 Searchable text:
EP000002187741B1 Original document:
WO002009023232 Searchable text:
WO002009023232 |
43 | Date of first publication | EVT | Feb 19, 2009 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Jul 30, 2024 (Show all update days)(Hide all update days)- Jul 30, 2024
- May 27, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 10)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Mar 15, 2024 |
| Issue number | HN | 17 |
| Year | PJ | 2024 |
| Publication date | VT | Apr 25, 2024 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Reata Pharmaceuticals Holdings, LLC, Plano, TX, US |
71/73 | Previous applicant/owner | INHF | Reata Pharmaceuticals, Inc., Irving, Tex., US |
| Date of update of the procedure | REGT | Apr 25, 2024 |